Title:Advancements in Treatment Options of Women Infertility
Volume: 17
Issue: 2
Author(s): Nahid Lorzadeh*, Yasaman Kazemirad and Nastran Kazemirad
Affiliation:
- Department of Obstetrics and Gynecology, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad,Iran
Keywords:
Polycystic ovarian syndrome (PCOS), infertility, fertilization, women, tissue engineering, hormonal stimulation.
Abstract: Infertility is defined as the inability to conceive a pregnancy after one year or more of
unprotected sexual intercourse, among the women at the risk of conceiving a pregnancy. In addition
to the age factor, it is known to be associated with pathological and genetic conditions that
contribute to its early onset. Polycystic ovarian syndrome (PCOS), endometriosis, fibroids, and
blockade in fallopian tubes are certain common pathological causes of female infertility. Researches
are focused to eradicate the primary cause of infertility to achieve healthy fertile ground for fertilization.
Depending on the cause, therapeutic options include medicines (chemical, herbal and
Chinese), hormonal stimulation, surgery, assistive reproductive technology, and tissue engineering.
To the extent of research, biotechnology has played a significant role to answer the problem. This
review discusses advancements in these therapeutic fields to treat women-associated infertility.
